Sinopharm Group Guangdong Yuexing Co., Ltd. announced that it will receive CNY 70,000,000 in an equity round of funding from existing investor China National Accord Medicines Corporation Ltd. on October 8, 2014. The investor will continue to hold 100% stake in the company upon completion of the transaction. The registered capital of the company will increase from CNY 30,000,000 to CNY 100,000,000 upon completion of the transaction.

On the same date, the transaction was approved at the 2nd session of the 7th directorate meeting of the investor. The transaction is subject to approval at the 2014 3rd special stockholders' meeting of the investor. The company reported total assets of CNY 502,470,000, net assets of CNY 60,700,000, and revenues of CNY 1,246,990,000 for the year 2013.